CLINICAL_TRIALS
trial_result
· 2012-07-04
Clinical Trial Update: An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease [Phase 3]
Summary
Phase 3 clinical trial evaluating galantamine for Alzheimer's disease has completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-07-04